drugset / Trial / NCT07280234

Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.

NCT07280234

Phase 0 Completed 218 enrolled Hayat Abad Medical Complex, Peshawar
RandomizedParallel-groupOpen-labelTreatment

Summary

In this study we compared the effect of intradermal microinjections of tranexamic acid vs oral tranexamic acid in treatment of melasma. Given the high prevalence of melasma in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar, this study will provide valuable insights into optimal treatment strategies

Timeline

Start
2024-11-14
Primary completion
2025-05-15
Completion
2025-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 0.05 ml Other
Comparator Tranexamic Acid Small molecule 4 mg/ml Other
Comparator Tranexamic Acid Small molecule 250 mg Other